The group of Anna Dimberg has shown that in a murine glioblastoma model, pleiotrophin activates the anaplastic lymphoma kinase 1 (ALK1), which acts as its receptor and leads to VEGF deposition and vascular abnormalities in gliomas. The gene discussed is VEGFA; the disease is central nervous system cancer.